WeVote
Log In

Bill

Bill

A 9001

Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program

2025 Regular Session Introduced by Keith Brown and 11 co-sponsors

Bill A 9001 establishes a test strip program to help individuals detect harmful substances in drugs, enhancing safety and informed decision-making for users.

DELIVERED TO SENATE
0
WeVote Research Nonpartisan
Bill Summary · A 9001

Summary of Bill A 9001

Bill Information

  • Bill Number: A 9001
  • Title: Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program
  • Status: Referred to Alcoholism and Drug Abuse
  • Introduced: August 13, 2025
  • Classification: Bill

Purpose and Intent

Bill A 9001 aims to address the growing concerns surrounding substance use and the presence of harmful contaminants in drugs. The primary intent of this legislation is to establish a test strip program that allows individuals to test for the presence of specific substances, including medetomidine, benzodiazepines, nitazenes, and other harmful contaminants. This initiative is designed to enhance public health and safety by providing users with the tools to make informed decisions regarding drug use.

Key Provisions

  • Test Strip Program: The bill proposes the creation of a program that distributes test strips capable of detecting the presence of medetomidine, benzodiazepines, nitazenes, and other harmful substances in drugs.
  • Accessibility: The program will ensure that these test strips are readily available to individuals at risk of substance use, including those in harm reduction programs, community health organizations, and other relevant entities.
  • Education and Awareness: Alongside the distribution of test strips, the bill emphasizes the importance of educational initiatives to inform users about the risks associated with these substances and the proper use of test strips.
  • Data Collection: The program may include provisions for collecting data on the usage and effectiveness of the test strips, which can help inform future public health strategies.

Affected Parties

  • Individuals at Risk: The primary beneficiaries of this program will be individuals who use drugs, particularly those who may be unaware of the presence of harmful contaminants in their substances.
  • Public Health Organizations: Community health organizations and harm reduction programs will play a crucial role in distributing the test strips and providing education to users.
  • Healthcare Providers: Medical professionals may also be impacted as they may need to adapt their practices based on the findings and data collected from the program.

Procedural Aspects

  • Current Status: As of August 13, 2025, the bill has been referred to the Committee on Alcoholism and Drug Abuse for further consideration.
  • Next Steps: The bill will undergo discussions and potential amendments within the committee before it can proceed to a vote in the legislative assembly.

Conclusion

Bill A 9001 represents a proactive approach to addressing substance use and the associated risks of harmful contaminants. By establishing a test strip program, the legislation seeks to empower individuals with knowledge and tools to make safer choices, ultimately contributing to improved public health outcomes.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.